Facebook Linkedin RSS Twitter Youtube
Home 2016

Drug regulation

Are Biotechnology Patents Dead?
Insights

Are Biotechnology Patents Dead?

Endo Testosterone Replacement Therapy Aveed Wins FDA Approval
News

Endo Testosterone Replacement Therapy Aveed Wins FDA Approval

Dendreon Gets Green Light in Europe
Cancer

Dendreon Gets Green Light in Europe

BD Expands Into Prefilled Generic Injectables
News

BD Expands Into Prefilled Generic Injectables

Inlyta Approved in Europe for Advanced Renal Cell Carcinoma
Cancer

Inlyta Approved in Europe for Advanced Renal Cell Carcinoma

FDA Approves XenoPort, GSK’s Horizant for Managing Postherpetic Neuralgia
Drug Discovery

FDA Approves XenoPort, GSK’s Horizant for Managing Postherpetic Neuralgia

FDA Clears Novo Nordisk’s Levemir for Diabetic Children Aged Two Years and Over
News

FDA Clears Novo Nordisk’s Levemir for Diabetic Children Aged Two Years and Over

Regeneron and Bayer HealthCare Achieve Success in Second Phase III Study with Macular Edema Drug
News

Regeneron and Bayer HealthCare Achieve Success in Second Phase III Study with Macular Edema Drug

FDA Panel Hearing Suggests Medical Professionals May Play Role in Direct-to-Consumer Testing
Insights

FDA Panel Hearing Suggests Medical Professionals May Play Role in Direct-to-Consumer Testing

FDA Green-Lights Novartis’ Tasigna as First-Line Therapy for Newly Diagnosed Ph+ CML
Cancer

FDA Green-Lights Novartis’ Tasigna as First-Line Therapy for Newly Diagnosed Ph+ CML

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.